产品说明书

Lalistat 1

Print
Chemical Structure| 501104-16-1 同义名 : -
CAS号 : 501104-16-1
货号 : A1082368
分子式 : C12H18N4O3S
纯度 : 98%
分子量 : 298.361
MDL号 : MFCD03622084
存储条件:

粉末 Inert atmosphere,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 18 mg/mL(60.33 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 Lalistat 1 is a potent, selective, competitive inhibitor of lysosomal acid lipase (LAL) with an IC50 of 68 nM[1].Lalistat 1 is also an inhibitor of the immunoglobulin A1 protease (IgA1P) proteases of H. influenzae, and is weak against other serine hydrolases (trypsin or β-lactamase, etc.). Lalistat 1 can be used to study Niemann's rickets type C (NPC) disease[2].It is active against different non-typeable Haemophilus influenzae (NTHi) IgAP variants from clinical isolates at concentrations less than 100 μM in Elisa assays. It dose-dependently inhibited IgA1P B1 and B2, but at higher inhibitor concentrations, consistent with the higher expression levels of these variants. Inhibition of IgA1P B1 and B2 is almost complete at 50 μM and complete at 100 μM[1].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

3.35mL

0.67mL

0.34mL

16.76mL

3.35mL

1.68mL

33.52mL

6.70mL

3.35mL

参考文献

[1]Anton I Rosenbaum , et al. Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics. J Med Chem . 2010 Jul 22;53(14):5281-9.

[2]Livia Shehaj, et al. Small-Molecule Inhibitors of Haemophilus influenzae IgA1 Protease.ACS Infect Dis. 2019 Jul 12;5(7):1129-1138.